Literature DB >> 12903885

Arginine supplementation enhances peritoneal macrophage phagocytic activity in rats with gut-derived sepsis.

Yi-Yun Wang1, Huey-Fang Shang, Yu-Ni Lai, Sung-Ling Yeh.   

Abstract

BACKGROUND: Previous reports have shown that arginine (Arg) enhances phagocytic activity of macrophages and is required for macrophage-mediated toxicity toward tumor cells. Few studies have addressed the importance of Arg supplementation on macrophage and neutrophil function after infection and sepsis. This study examined the effect of Arg-supplemented diets before and Arg-enriched total parenteral nutrition (TPN) after sepsis or both on the phagocytic activity of peritoneal macrophages and blood polymorphonuclear cells in rats with gut-derived sepsis.
METHODS: Male Wistar rats were assigned to 4 groups. Groups 1 and 2 were fed a semipurified diet, while groups 3 and 4 had part of the casein replaced with 2% of total calories as Arg. After the experimental diets were administered for 10 days, sepsis was induced by cecal ligation and puncture (CLP); at the same time, an internal jugular vein was cannulated. All rats were maintained on TPN for 3 days. Groups 1 and 3 were infused with conventional TPN, while groups 2 and 4 were supplemented with Arg, replacing 10% of total amino acids in the TPN solution. Survival rates were recorded for 3 days after CLP, and all surviving rats were killed 3 days after CLP to examine their immune responses.
RESULTS: Aerobic and anaerobic bacteria colony counts in peritoneal lavage fluid were significantly reduced, and the phagocytic activity of peritoneal macrophages was enhanced in groups 3 and 4 but not in the other 2 groups. There were no significant differences in the phagocytic activities of blood polymorphonuclear cells and survival rates among the 4 groups.
CONCLUSIONS: Enteral Arg supplementation before sepsis significantly enhanced peritoneal macrophage phagocytic activity and reduced total bacterial counts in peritoneal lavage fluid. Arg administered before and after CLP seemed to have a synergistic effect on enhancing phagocytic activity and on bacterial clearance. However, IV Arg administration after CLP had no favorable effects on phagocytic activity or survival rates in rats with gut-derived sepsis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12903885     DOI: 10.1177/0148607103027004235

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

1.  Does pharmacological dose of parenteral arginine have beneficial effect in rats with sub-acute peritonitis?

Authors:  Hui-Chen Lo; Shih-Chi Wu; Yao-Horng Wang; Chien-Hsing Lee
Journal:  Pediatr Surg Int       Date:  2010-02-24       Impact factor: 1.827

2.  Effects of arginine supplementation on splenocyte cytokine mRNA expression in rats with gut-derived sepsis.

Authors:  Huey-Fang Shang; Chun-Sen Hsu; Chiu-Li Yeh; Man-Hui Pai; Sung-Ling Yeh
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 3.  Role of Arginine and Omega-3 Fatty Acids in Wound Healing and Infection.

Authors:  J Wesley Alexander; Dorothy M Supp
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-11-01       Impact factor: 4.730

Review 4.  Arginine depletion increases susceptibility to serious infections in preterm newborns.

Authors:  Shiraz Badurdeen; Musa Mulongo; James A Berkley
Journal:  Pediatr Res       Date:  2014-10-31       Impact factor: 3.756

5.  Intravenous Arginine Administration Downregulates NLRP3 Inflammasome Activity and Attenuates Acute Kidney Injury in Mice with Polymicrobial Sepsis.

Authors:  Sharon Angela Tanuseputero; Ming-Tsan Lin; Sung-Ling Yeh; Chiu-Li Yeh
Journal:  Mediators Inflamm       Date:  2020-05-11       Impact factor: 4.711

6.  Serine Supports IL-1β Production in Macrophages Through mTOR Signaling.

Authors:  Siyuan Chen; Yaoyao Xia; Fang He; Jian Fu; Zhongquan Xin; Baichuan Deng; Liuqin He; Xihong Zhou; Wenkai Ren
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.